USG Humanitarian Assistance to EVD Outbreak Response to Date in FY 2014 & FY 2015

The total committed USG funding to date is $963,184,373. USAID's Office of U.S. Foreign Disaster Assistance (USAID/OFDA) has provided $462,204,608, while USAID's Office of Food for Peace (USAID/FFP) has contributed $43,739,529. USAID's Bureau for Global Health (USAID/GH) has allocated $20,076,000, and USAID/Liberia has provided $5,000,000. USAID/Guinea has contributed $3,482,000, and the U.S. Department of Defense (DoD) has provided $326,531,000. The U.S. Centers for Disease Control and Prevention (CDC) has received $102,151,236 in funding. The EVD outbreak in West Africa has resulted in a significant number of cases and deaths. As of February 11, 2015, the total number of suspected, probable, and confirmed EVD cases in acutely affected countries was 22,859, with 9,162 deaths attributed to EVD. The number of EVD cases in Sierra Leone was 10,934, in Liberia was 8,881, and in Guinea was 3,044. The WHO reported that the total weekly case incidence increased across West Africa, with 144 newly confirmed cases recorded between February 1 and 8. Community resistance to EVD response efforts continues in Guinea and Sierra Leone. The UN reported security incidents or community refusal to cooperate with EVD response activities in 10 of Guinea's 34 prefectures during the final week of January. In Sierra Leone, three districts reported at least one incident of resistance to EVD response efforts in late January. However, the Guinean Ministry of Education reports that approximately 99 percent of schools have reopened, with only 70 schools still closed, according to the UN. In Liberia, the Government of Liberia reported 135 new suspect and probable cases across the country between February 2 and 8, with only three newly confirmed cases. As of February 9, only three counties had documented a confirmed case during the previous 42 days, marking the passage of two 21-day monitoring periods without a confirmed case in 12 of Liberia's 15 counties. USAID/OFDA partners Mercy Corps and Population Services International (PSI) have trained more than 900 community mobilizers through the Ebola Community Action Platform (E-CAP) program. In Sierra Leone, the Port Loko District Ebola Response Center (DERC) reported 36 confirmed EVD cases for the district during the week of January 26, a marked increase compared to the 10 cases reported from the previous week. The cases in Port Loko are largely responsible for the recent plateau in a previously declining EVD trend. The main cause of recent transmission is a small number of unsafe burials, according to the WHO. With USAID/OFDA support, International Organization for Migration (IOM) is conducting social mobilization activities in Port Loko to promote EVD awareness and safe practices. In Guinea, health actors are expanding clinical trials of Favipiravir, an influenza pharmaceutical from Japan used to treat EVD patients in Europe. The Institut national de la santé et de la recherche médicale (INSERM), a French medical research institute, began conducting Favipiravir trials in December at an ETU in Guéckédou Prefecture. The Government of Guinea will allow healthcare workers to administer the experimental drug at ETUs in N'Zérékoré and Coyah prefectures.